Industrial production of β-lactam antibiotics

Applied Microbiology and Biotechnology

Volumn 61, Issue 5-6, 2003, Pages 385-392

  Elander, R P ^a  

^a Biotechnology Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINOPENICILLANIC ACID; 7 AMINOCEPHALOSPORANIC ACID; AMOXICILLIN; AMPICILLIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BACAMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBENICILLIN; CEPHALOSPORIN C; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CLOXACILLIN; DEACETOXYCEPHALOSPORIN C; DICLOXACILLIN; FLUCLOXACILLIN; MACROLIDE; METICILLIN; MEZLOCILLIN; NAFCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TICARCILLIN; UNINDEXED DRUG;

ANTIBIOTICS; BIOTECHNOLOGY;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BIOTECHNOLOGY; CEPHALOSPORIUM ACREMONIUM; COST CONTROL; DRUG COST; DRUG DECOMPOSITION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG SYNTHESIS; FED BATCH FERMENTATION; HYDROLYSIS; NONHUMAN; PENICILLIUM CHRYSOGENUM; SHORT SURVEY;

ACREMONIUM CHRYSOGENUM; CEPHALOSPORIUM; PENICILLIUM; PENICILLIUM CHRYSOGENUM;

EID: 0038236925     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-003-1274-y     Document Type: Short Survey

References (34)

1. Albers-Schoenberg G, Arison BH, Hensens OD, Hirshfield J, Hoogsteen K, Kaczka EA, Rhodes RE, Kahan JJ, Kahan FM, Ratcliffe RW, Walton E, Ruswinkle LJ, Morin RB, Christiansen BG (1978) The structure and absolute configuration of thienamycin. J Am Chem Soc 100:6491-6499
2. Barber M (1996) The penicillins business. Michael Barber and Associates, 18 Croydon Road, Catterham, Surrey, UK
3. Barber M (2000) The cephalosporins business: 2000 and beyond. Michael Barber and Associates, 18 Croydon Road, Catterham, Surrey, UK
4. Basch J, Chiang S-JD (1998) Genetic engineering approach to reduce undesirable products in cephalosporin C fermentation. J Ind Microbiol Biotechnol 20:344-351
5. Brakhage AA (1998) Molecular regulation of β-lactam biosynthesis in filamentous fungi. Microbiol Mol Biol Rev 62:547-585
6. Brown AG, Butterworth D, Cole M, Hanscomb G, Hood JD, Reading C, Rolinson CN (1976) Naturally occurring β-lactamase inhibitors without antibacterial activity. J Antibiot 29:668-669
7. Cantwell CA, Beckman RJ, Dotzlaf JE, Fisher DL, Skatrud PL, Yeh WH, Queener SW (1990) Cloning and expression of a hybrid Streptomyces clavuligerus cef E gene in Penicillium chrysogenum. Curr Genet 17:213-221
8. Cantwell CA, Beckman R, Whiteman P, Queener SW, Abraham E (1992) Isolation of deacetoxycephalosporin C from fermentation broths of Penicillium chrysogenum transformants: construction of a new biosynthetic pathway. Proc R Soc London B 238:283-289
9. Chiang SJ, Chang LT, Chen YS, Hou HH, Elander RP (1991) Strain improvement in Penicillium chrysogenum, from classical genetics to genetic engineering. In: Kleinkauf H, von Dohren H (eds) 50 years of penicillin applications: history and trends. Public, Czech Republic, pp 245-257
10. Chiang S-JD, Basch J (1999) Cephalosporins. In: Flickinger MC, Drew SW (eds) Encyclopedia of bioprocess technology: fermentations, biocatalysis and bioseparations, vol 1. Wiley, New York, pp 560-570
11. Crawford L, Stepan AM, McAda PC, Rambosek JA, Conder MJ, Vinci VA, Reeves CD (1995) Production of cephalosporin intermediates by feeding adipic acid to recombinant Penicillium chrysogenum strains expressing ring expansion activity. Biotechnology 13:58-62
12. Demain AL, Elander RP (1999) The β-lactam antibiotics: past, present and future. Antonie van Leeuwenhoek 75:5-19
13. Demain AL, Martin JF, Elander RP (1998) Penicillin biochemistry and genetics. In: Mateles RI (ed) Penicillin: a paradigm for biotechnology. Candida, Chicago, pp 98-114
14. Elander RP, Chiang S-J (1991) Genetics and antibiotic process improvement: from classical genetics to genetic engineering. In: Procop A, Bajpai RK, Ho C (eds) Recombinant DNA technology and applications. McGraw-Hill, New York, pp 153-170
15. Howarth TT, Brown AG, King TJ (1976) Clavulanic acid, a novel β-lactam isolated from Streptomyces clavuligerus: X-ray crystal structure analysis. J Chem Soc Chem Commun 266-267
16. Kahan JS, Kahan FM, Goegelman R, Currie SA, Jackson M, Stapley EO, Miller TW, Hendlin D, Mochales S, Hernandez S, Woodrull HB, Birnbaum J (1979) Thienamycin, a new betalactam antibiotic. 1, discovery, taxonomy, isolation and physical properties. J Antibiot 32:1-12
17. Lawrence GC, Lilly G (1980) UK Patent 1,571,888
18. Matsumoto K (1993) Production of 6-APA, 7-ACA and 7-ADCA by immobilized cephalosporin amidase. In: Tanaka A, Tosa T, Kobayashi T (eds) Industrial application of immobilized biocatalysis. Dekker, New York, pp 67-88
19. Miller TW (1981) Crystalline N-formimidoylthienamycin. US Patent 4,260,543
20. Morin RB, Jackson BG, Mueller RA, Lavagnino ER, Scanlon WB, Andrews SL (1963) Chemistry of cephalosporin antibiotics. 3. Chemical correlation of penicillin and cephalosporin antibiotics. J Am Chem Soc 85:1896-1897
21. Nagarajan R (1972) β-Lactam antibiotics from Streptomyces. In: Flynn EH (ed) Cephalosporins and penicillins: chemistry and biology. Academic Press, New York, pp 636-661
22. Reading E, Cole M (1977) Clavulanic acid: a beta-lactamase inhibitor from Streptomyces clavuligerus. Antimicrob Agents Chemother 11:852-857
23. Rowlands RT (1991) Industrial strain improvement and the Panlabs penicillin club. In: Kleinkauf H, von Dohren H (eds) 50 years of penicillin applications: history and trends. Public, Czech Republic, pp 258-266
24. Savidge TA (1984) Enzymatic conversion used in the production of penicillins and cephalosporins. In: Vandamme E (ed) Biotechnology of industrial antibiotics. Dekker, New York, pp 191-224
25. Skatrud PL, Tietz AJ, Ingolia TD, Cantwell CA, Fisher DC, Chapman JL, Queener SW (1989) Use of recombinant DNA to improve the production of cephalosporin C by Cephalosporium acremonium. Biotechnology 7:477-485
26. Stapley EO, Jackson M, Hernandez S, Zimmerman SB, Currie SA, Mochalis S, Mahta JM, Woodruff HB, Hendlin D (1972) Cephamycins, a new family of β-lactam antibiotics. 1. Production by actinomycetes, including Streptomyces lactamdurans sp. n. Antimicrob Agents Chemother 2:122-131
27. Stapley EO, Birnbaum J, Miller AK, Wallick H, Hendlin D, Woodruff HB (1979) Cefoxitin and cephamycins: microbiological studies. Ref Infect Dis 1:73-87
28. Strohl WR (1999) Secondary metabolites; antibiotics. In: Flickinger MC, Drew SW (eds) Encyclopedia of bioprocess technology: fermentation, biocatalysis and bioseparations, vol 5. Wiley, New York, pp 2348-2365
29. Sylvester JC, Coghill RD (1954) The penicillin fermentation. In: Underkofler LA, Hickey RJ (eds) Industrial fermentations, vol 2. Chemical Publishing, New York, pp 219-263
30. Usher JJ, Lewis MA, Hughes DW, Compton BJ (1988) Development of the cephalosporin C fermentation taking into account the instability of cephalosporin C. Biotechnol Lett 10:543-548
31. Van der Beck CP, Roels JA (1984) Penicillin production: biotechnology at its best. Antonie van Leeuwenhoek 50:625-639
32. Van Nistelrooij, Krijgsman J, DeVroom E, Oldenhof C (1998) Penicillin update. In: Mateles RI (ed) Penicillin: a paradigm for biotechnology. Candida, Chicago, pp 85-91
33. Waites MJ, Morgan NL, Rockey JS, Higton G (2001) Industrial microbiology: an introduction. Blackwell, Oxford, UK
34. Weissenberger HWO, van der Hoeven MB (1970) An efficient non-enzymatic conversion of benzylpenicillin to 6-aminopenicillanic acid. Recl Trav Chim Pays-Bas 89:1081-1084